mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.003 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |